Accepted at 7:28 p.m. Jan, 06, 2024 by zarathustra
Author: zarathustra
Related Note: 1481330754322
Rationale for change

a table may be more suited in this case, since the extra field is basically a comparison between 2 characteristics of leukemoid reaction and chronic myeloid leukemia

Extra Extra
Text
Chronic myeloid leukemia (CML) is distinguished from a leukemoid reaction (benign neutrophilia) by presence of increased {{c1::basophils::cell type}}
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid


Sketchy

Watch Acute Myeloid Leukemia (AML) & Chronic Myeloid Leukemia (CML)
Sketchy 2

Watch Chronic Leukemias SOAP
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize


Review Basophils


Review Chronic Myelogenous Leukemia (CML)
Physeo
Empty field
Bootcamp
Watch associated Bootcamp video - Leukemias and Lymphomas: Chronic Myeloid Leukemia

Watch associated Bootcamp video - Blood Cells: Basophil
OME

Additional Resources
presence of basophilia and less mature neutrophil precursors (myelocytes > metamyelocytes) favors diagnosis of CML > leukemoid reaction; think of metamyelocyte = more words = more mature





Other:
One by one
Empty field
#AK_Step2_v12::#AMBOSS::o-a0yM #AK_Step2_v12::#AMBOSS::xt0Ef3 #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Leukemia #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::29_Myeloproliferative_neoplasms::*Chronic_Myeloproliferative_Disorders::Chronic_Myelogenous_Leukemia #AK_Step2_v12::#OME::01_Medicine::05_Hematology_Oncology::05_Leukemia #AK_Step2_v12::#Resources_by_rotation::IM::ome::heme/onc::leukemia #AK_Step2_v12::#SketchyIM::08_Hematology_&_Oncology::04_Oncology::02_Chronic_Leukemias_SOAP #AK_Step1_v12::#AMBOSS::IQaYx4 #AK_Step1_v12::^Other::^EXPN::BGedit #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::03_White_Cells::04_Chronic_Leukemias #AK_Step2_v12::#Resources_by_rotation::IM::uw::heme/onc::heme/onc_zanki #AK_Step1_v12::#Physeo::11_Pathology::10_HemeOnc_Pathology::14_Myeloproliferative_Disorders #AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Hematology_&_Oncology::Pathoma_WBC #AK_Step1_v12::^Other::^HighYield::2-RelativelyHighYield #AK_Step1_v12::#UWorld::COMLEX::24680 #AK_Step1_v12::#B&B::11_Hematology::03_White_Blood_Cells::02_Chronic_Leukemia #AK_Step2_v12::Original_decks::Zanki_Step_2::IM::HemeOnc #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::09_Leukemias_and_Lymphomas::02_Chronic_Myeloid_Leukemia #AK_Step1_v12::#SketchyPath::10_Myeloid_&_Lymphoid::01_Myeloid_Disorders::02_Acute_Myeloid_Leukemia_(AML)_&_Chronic_Myeloid_Leukemia_(CML) #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::29_Myeloproliferative_neoplasms::*Chronic_Myeloproliferative_Disorders::Leukemoid_Reaction #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::02_Blood_Cells::04_Basophil #AK_Step2_v12::#AMBOSS::Et0823 !AK_UpdateTags::Step1decks::Zanki-Step-Decks::Zanki-Hematology-&-Oncology::Pathoma-WBC #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step1_v12::#UWorld::Step::1569 #AK_Step1_v12::#Pathoma::06_WBC::04_Myeloproliferative #AK_Step1_v12::^Systems::HemeOnc::WBC #AK_Step1_v12::^Other::^EXPN::Uworld #AK_Step1_v12::#Pixorize::02_Immunology::07_Leukemias_&_Lymphomas::04_Chronic_Myelogenous_Leukemia_(CML) #AK_Step1_v12::#Pixorize::02_Immunology::03_Other_Cell_Types::04_Basophils #AK_Step1_v12::#AMBOSS::Y4an3k #AK_Step2_v12::#AMBOSS::Dt01f3 #AK_Step2_v12::Original_decks::Dorian::im::uw::heme/onc #AK_Step2_v12::Original_decks::Dorian::im::ome::heme/onc::leukemia #AK_Step2_v12::#Resources_by_rotation::IM::uw::heme/onc::heme/onc_dorian